Related Experiment Video

Updated: Sep 7, 2025

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
08:26

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression

Published on: February 17, 2012

14.7K

Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for

Jinxin Liu1, Ting Chen1, Shizhe Li1

  • 1Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.

Seminars in Cancer Biology
|June 20, 2022
PubMed

Insights

Matrix metalloproteinases (MMPs) drive cancer progression by altering the tumor microenvironment. Targeting E3 ubiquitin ligases offers a novel therapeutic strategy to inhibit MMPs for effective cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The tumor microenvironment (TME) is crucial in cancer development.
  • Matrix metalloproteinases (MMPs) significantly influence tumorigenesis by degrading the extracellular matrix (ECM) and promoting metastasis.
  • MMPs are regulated by TIMPs, signaling pathways, noncoding RNAs, and E3 ubiquitin ligases.

Purpose of the Study:

  • To review the molecular mechanisms of MMP regulation by E3 ubiquitin ligases in carcinogenesis.
  • To explore the therapeutic potential of targeting E3 ubiquitin ligases for MMP inhibition in cancer therapy.

Main Methods:

  • Literature review focusing on E3 ubiquitin ligases' role in MMP regulation.
  • Analysis of current therapeutic strategies targeting MMPs and their limitations.
  • Discussion of novel therapeutic approaches targeting E3 ubiquitin ligases.

Main Results:

  • E3 ubiquitin ligases play a critical role in controlling MMP expression and activity.
  • Existing MMP-targeting therapies face challenges like poor solubility and side effects.
  • Targeting E3 ubiquitin ligases presents a promising alternative for MMP-driven cancer treatment.

Conclusions:

  • Understanding MMP regulation by E3 ubiquitin ligases is key for developing new cancer therapies.
  • Targeting E3 ubiquitin ligases offers a novel strategy to overcome limitations of current MMP inhibitors.
  • This review highlights the therapeutic potential of E3 ubiquitin ligases in combating various human cancers.
Keywords:
CancerE3 ligasesMMPsTMETherapy

More Related Videos

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System10:55

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System

Published on: January 8, 2018

11.2K
Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion05:48

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

9.9K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K